Skip to main content

Peer Review reports

From: Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

Original Submission
27 Dec 2011 Submitted Original manuscript
12 Jan 2012 Reviewed Reviewer Report - Antonio Frassoldati
11 Mar 2012 Reviewed Reviewer Report - Sara Hurvitz
11 Apr 2012 Author responded Author comments - Alessandra Fabi
Resubmission - Version 2
11 Apr 2012 Submitted Manuscript version 2
2 Jul 2012 Reviewed Reviewer Report - Antonio Frassoldati
3 Jul 2012 Reviewed Reviewer Report - Sara Hurvitz
6 Aug 2012 Author responded Author comments - Alessandra Fabi
Resubmission - Version 3
6 Aug 2012 Submitted Manuscript version 3
2 Sep 2012 Reviewed Reviewer Report - Sara Hurvitz
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Sep 2012 Editorially accepted
19 Oct 2012 Article published 10.1186/1471-2407-12-482

You can find further information about peer review here.

Back to article page